Ricardo M. Attar

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

John S. Sack, Kevin Kish, Chihuei Wang et al. · Proceedings of the National Academy of Sciences · 2001 · 483 citations · Full text

BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

Joan M. Carboni, Mark D. Wittman, Zheng Yang et al. · Molecular Cancer Therapeutics · 2009 · 278 citations · Full text

Small Molecule Inhibitor, Cancer Biology, Insulin Signaling +16

A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors

Sheri L. Moores, Mark L. Chiu, Barbara S. Bushey et al. · Cancer Research · 2016 · 262 citations

Cmet Is Effective, Medicine, Receptor Tyrosine Kinase +15

Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail

Hyun Jung Kim, Beate C. Litzenburger, Xiaojiang Cui et al. · Molecular and Cellular Biology · 2007 · 247 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Antitumor Effects of the Dual Insulin-Like Growth Factor-I/Insulin Receptor Inhibitor, BMS-554417

Paul Haluska, Joan M. Carboni, David A. Loegering et al. · Cancer Research · 2006 · 177 citations